PhaseV
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$15M
PhaseV is a company that specializes in causal machine learning technology for optimizing clinical trial design and analysis, using advanced causal inference to detect hidden signals in clinical data and extract actionable insights for planning the optimal next steps.
Focus Areas
Clinical Trial Optimization
Causal Machine Learning
Clinical Data Analysis
Adaptive Trial Design
Drug Development Process
AI in Healthcare
Investors
